Latest stories on MDCX
Medicus Pharma Elevates Precision Oncology Profile With Global Conference Appearances
TipRanks58 · neutralproduct/pr
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
Business Insider53 · neutralproduct/pr
Medicus Pharma restores Nasdaq compliance; stock rises premarket
Seeking Alpha64 · neutralgeneral
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire62 · neutralgeneral
Medicus Pharma Ltd. (MDCXW) files 8-K
SEC 8-K34 · bearishgeneral
Medicus Pharma Ltd. (MDCXW) files 8-K
SEC 8-K50 · neutralgeneral
MedinCell downgraded to Hold from Buy at Kepler Cheuvreux
The Fly34 · bearishanalyst
Medicus Pharma Ltd trading halted, news pending
The Fly50 · neutralgeneral
Medicus Pharma Outlines Clinical Development Strategy Across Three Drug Programs Following $90 Million in Financing
InvestorsHub58 · neutralproduct/pr
Medicus Pharma cites about $90M raised to advance CD228V, SkinJect, Teverelix
The Fly28 · bearishgeneral
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
GlobeNewswire58 · neutralproduct/pr
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
Business Insider58 · neutralproduct/pr
Medicus Pharma Ltd. (MDCXW) files 8-K
SEC 8-K50 · neutralgeneral
Medicus Healthcare Solutions Releases 2026 Report on Rising Demand in Emergency Medicine
PR Newswire56 · neutralproduct/pr
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
GlobeNewswire63 · neutralproduct/pr
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
Business Insider63 · neutralproduct/pr
Medicus to focus future clinical development of SkinJect on Gorlin syndrome
The Fly56 · neutralproduct/pr
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
Business Insider56 · neutralproduct/pr
Medicus Pharma Ltd. (MDCXW) files 8-K
SEC 8-K42 · neutralgeneral
Medicus Pharma price target raised to $1 from 90c at Alliance Global
The Fly58 · neutralanalyst
Medicus Pharma Announces Equity-Based Bonus Share Issuance
TipRanks24 · bearishgeneral
Medicus Pharma Ltd. (MDCXW) files 8-K
SEC 8-K50 · neutralgeneral